List of insiders holdings for Cue Biopharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Azam Usman CHIEF EXECUTIVE OFFICER | 2025-10-02 20:13:23 | 1,875,000 0 | 1,875,000 | Form 4 |
| 2 | MARLETT CHRISTOPHER A Director | 2020-04-21 15:16:03 | 1,357,821 0 | 1,357,821 | Form 13D |
| 3 | Lin Shao-Lee Chief Executive Officer | 2026-10-14 21:37:35 | 694,908 0 | 694,908 | Form 4 |
| 4 | Gray Cameron Director | 2022-06-16 16:01:21 | 687,049 0 | 687,049 | Form 4 |
| 5 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 2025-03-25 16:00:09 | 450,000 0 | 450,000 | Form 4 |
| 6 | Warren Lucinda CHIEF BUSINESS OFFICER | 2026-04-10 16:00:05 | 250,000 0 | 250,000 | Form 4 |
| 7 | Levisetti Matteo Chief Medical Officer | 2025-03-25 16:00:03 | 250,000 0 | 250,000 | Form 4 |
| 8 | Sandercock Colin SVP, GENERAL COUNSEL | 2026-04-10 16:00:06 | 200,000 0 | 200,000 | Form 4 |
| 9 | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 2025-03-25 16:00:10 | 200,000 0 | 200,000 | Form 4 |
| 10 | Mancilla Bethany SVP and Chief Business Officer | 2019-03-08 16:13:39 | 165,000 0 | 165,000 | Form 4 |
| 11 | Suri Anish PRESIDENT AND CSO | 2024-06-07 16:00:10 | 150,000 0 | 150,000 | Form 4 |
| 12 | Ray Sumita Chief Legal Compliance Officer | 2026-10-14 21:39:34 | 116,701 0 | 116,701 | Form 4 |
| 13 | Baker Daniel G. CHIEF DEVELOPMENT OFFICER | 2026-04-10 16:00:03 | 100,000 0 | 100,000 | Form 4 |
| 14 | NASSHORN PATRICIA Chief Business Officer | 2023-02-21 17:03:07 | 97,900 0 | 97,900 | Form 4 |
| 15 | Borie Dominique Christian Chief Medical Officer | 2026-07-15 18:59:46 | 94,500 0 | 94,500 | Form 4 |
| 16 | SCHUMAN GARY ALAN Interim CFO | 2017-12-27 13:39:07 | 77,861 0 | 77,861 | Form 3 |
| 17 | Ahlers James M Chief Financial Officer | 2026-08-03 16:19:19 | 76,500 0 | 76,500 | Form 4 |
| 18 | Chaparro Rodolfo EVP, Head of Immunology | 2018-07-25 16:47:57 | 75,000 0 | 75,000 | Form 4 |
| 19 | Seidel Ronald D. III EVP, Head of R&D | 2018-07-25 16:49:37 | 75,000 0 | 75,000 | Form 4 |
| 20 | Fox Michael J Director | 2024-06-07 16:00:08 | 48,800 0 | 48,800 | Form 4 |
| 21 | Meluzio Michael Vincent VP, Prin. Accounting Officer | 2026-10-14 21:38:15 | 47,817 0 | 47,817 | Form 4 |
| 22 | Pienta Kenneth Chief Medical Officer | 2022-03-29 16:12:35 | 40,000 0 | 40,000 | Form 4 |
| 23 | DIGIANDOMENICO ANTHONY Director | 2019-01-04 18:21:42 | 30,000 0 | 30,000 | Form 4 |
| 24 | Sarraf Pasha Director | 2026-08-28 17:05:23 | 29,195 0 | 29,195 | Form 4/A |
| 25 | Verheyen Patrick Director | 2026-01-06 16:00:04 | 24,400 0 | 24,400 | Form 4 |
| 26 | Morich Frank Director | 2026-01-06 16:00:06 | 24,400 0 | 24,400 | Form 4 |
| 27 | Broadfoot Jill Marie Director | 2026-01-06 16:00:09 | 24,400 0 | 24,400 | Form 4 |
| 28 | Kiener Peter A Director | 2026-01-06 16:00:11 | 24,400 0 | 24,400 | Form 4 |
| 29 | DRISCOLL FREDERICK W Director | 2025-01-03 16:00:12 | 24,400 0 | 24,400 | Form 4 |
| 30 | Meehan Viola Mong Director | 2026-07-10 19:35:05 | 21,800 0 | 21,800 | Form 4 |
| 31 | Camardo Daniel A. Director | 2026-07-10 19:37:10 | 21,800 0 | 21,800 | Form 4 |
| 32 | Garzone Pamela Director | 2026-08-28 17:04:26 | 18,900 0 | 18,900 | Form 4/A |
| 33 | HOWSON TAMAR D Director | 2023-01-05 16:09:28 | 10,000 0 | 10,000 | Form 4 |
| 34 | Simon Barry J. Director | 2021-01-06 16:46:30 | 10,000 0 | 10,000 | Form 4 |
| 35 | Fletcher Aaron G.L. Director | 2023-01-05 16:08:51 | 10,000 0 | 10,000 | Form 4 |
| 36 | MCKNIGHT STEVEN L Director | 2020-01-06 17:58:28 | 8,000 0 | 8,000 | Form 4 |